Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amphastar Pharmaceuticals, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AMPH
Nasdaq
2830
www.amphastar.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amphastar Pharmaceuticals, Inc.
Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative?
- Dec 16th, 2025 9:07 am
3 Healthcare Stocks with Questionable Fundamentals
- Dec 15th, 2025 9:34 pm
Amphastar Announces FDA Approval for Teriparatide Injection
- Dec 15th, 2025 4:00 am
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges
- Dec 11th, 2025 9:33 pm
1 Stock Under $50 Worth Your Attention and 2 We Brush Off
- Dec 8th, 2025 9:34 pm
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead?
- Dec 5th, 2025 7:23 am
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why
- Dec 3rd, 2025 1:26 pm
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted?
- Nov 29th, 2025 8:11 am
A Look at Amphastar Pharmaceuticals (AMPH) Valuation Following Strong Quarterly Results and Pipeline Progress
- Nov 28th, 2025 7:08 pm
Amphastar (AMPH) Q3 2025 Earnings Call Transcript
- Nov 27th, 2025 4:11 pm
Amphastar Pharmaceuticals- Growth has been impressive, Can it continue?
- Nov 24th, 2025 8:16 am
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
- Nov 24th, 2025 4:00 am
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
- Nov 21st, 2025 4:55 pm
3 Small-Cap Stocks with Questionable Fundamentals
- Nov 17th, 2025 9:35 pm
Why Amphastar Pharmaceuticals (AMPH) Is Up 8.4% After Strong Q3 Revenue and Key FDA Approvals
- Nov 14th, 2025 8:13 pm
5 Must-Read Analyst Questions From Amphastar Pharmaceuticals’s Q3 Earnings Call
- Nov 12th, 2025 10:34 pm
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
- Nov 12th, 2025 1:20 pm
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
- Nov 12th, 2025 4:00 am
Generic Pharmaceuticals Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Simply the Best
- Nov 11th, 2025 8:31 pm
Why Are Amphastar Pharmaceuticals (AMPH) Shares Soaring Today
- Nov 10th, 2025 1:21 pm
Scroll